期刊文献+

2型糖尿病性视网膜病变PBMCs中miR-126表达的研究 被引量:3

Expression of miR-126 in PBMCs of diabetic retinopathy patients
原文传递
导出
摘要 目的探讨糖尿病性视网膜病变(DR)患者外周血单个核细胞(PBMCs)中miR-126的水平变化及其临床意义。方法临床病例对照研究。对2014年12月到2015年3月在滨州医学院附属医院内分泌科及眼科住院的76例患者分为无糖尿病性视网膜病变组(NDR组)30例,非增殖期糖尿病性视网膜病变组(NPDR组)25例,增殖期糖尿病性视网膜病变组(PDR组)21例,及正常对照组(CON组)30名。收集患者的-般检查结果,用逆转录PCR(RT—PCR)检测PBMCs中miR-126的水平,及酶联免疫吸附法(ELISA法)检测血浆中VEGF的水平。结果高密度脂蛋白(HDL)在PDR组明显高于NDR组和NPDR组,差异有统计学意义(P〈0.05)。PDR组的白细胞(WBC)数明显比其余三组高,差异有统计学意义(P〈0.05)。miR-126在NPDR组、PDR组明显低于CON组和NDR组,差异有统计学意义(P〈0.05)。与CON组相比,血浆中的VEGF在NDR组、NPDR组和PDR组中明显上调,差异有统计学意义(P〈0.05)。PBMCs中miR-126水平与FPG、VEGF差异有统计学意义(P〈0.05),(r=-0.67,P〈0.05,f=-0.74,P〈O.05)。结论PBMCs中miR-126参与到DR的发生及发展的过程,其水平变化与病程有关。 Objective To investigate the expression of miR-126 and the clinical significance in peripheral blood mononuclear cells (PBMCs) of patients with diabetic retinopathy (DR). Methods Seventy-six type 2 diabetes mellitus (DM) patients were assigned into four groups: non-diabetic reti- nopathy (NDR, n=30), non-proliferative diabetic retinopathy (NPDR, n=25), proliferative diabetic reti- nopathy (PDR, n=21) and control (CON, n=30). By RT-PCR, the expression of miR-126 in PBMCs was detected and the expression of plasma VEGF was analyzed using ELISA. Results The plasma level of high density lipoprotein (HDL) and the number of white blood cell (WBC) in PDR group was significant higher than that in NDR and NPDR groups (P 〈0.05). The expression of miR-126 in PDR and NPDR groups was lower than that in the NDR and CON groups (P 〈0.05). Compared with the CON group, ELISA showed a significant increasing of plasma VEGF in the NDR, NPDR and PDR groups (P 〈0.05). Moreover, there was a negative correlation between miR-126 in PBMCs and fasting plasma glucose (FPG) or VEGF (r =-0.67, P 〈0.05; r =-0.74, P 〈0.05). Conclusions The changes of miR-126 in PBMCs may participate in the onset and development of DR, and asso- ciated with the seriousness of DR.
出处 《中国实用眼科杂志》 2016年第4期322-325,共4页 Chinese Journal of Practical Ophthalmology
关键词 2型糖尿病 糖尿病性视网膜病变 PBMCS MIR-126 Type 2 diabetes mellitus Diabetic retinopathy Peripheral blood mononuclear cells(PBMCs) MiR-126
  • 相关文献

参考文献11

  • 1Scanlon PH,Aldington SJ,Stratton IM, et al. Epidemiological is- sues in diabetic retinopathy [J]. Middle East Afr J Ophthalmo, 2013,20(4) : 293-300.DOI : 10.4103/0974-9233.1200017.
  • 2Wang S,Aurora AB,Johnson BA, et al. The endothelial-specif- ic microRNA miR-126 governs vascular integrity and angiogene- sis [J]. Dev Cell, 2008, 15 (2) : 261 -271.DO1: 10.1016/j.dev- cel.2008.07.002.
  • 3Collares CV,Evangelista AF,Xavier DJ, et al. Identifying com- mon and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients [J]. BMC Res Notes,2013,26(6):491.DO1: 10.1186/1756-0500-6491.
  • 4. Mocharla P, Briand S, Giannotti G, et al. AngiomiR-126 expres- sion and secretion from circulating CD34+andCD14+PBMCs: role for proangiogenic effects and alterations in type 2 diabet- ics [J]. Blood,2013,121(1):226-236. DOI:10.1182/6100d-2013-O1- 407106.
  • 5Yu HC,Wu J, Zhang HX, et al. Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophre- nia patients [J]. Prog Neuropsychopharmaeol Biol Psychia- try.2015,16(63) : 23-29.DOI: 10.1016/j.pnpbp.2015.05.007.
  • 6Kaga H, Komatsuda A, Omokawa A, et al. Down-regulated ex- pression of miR-155, miR-17, and miR-181b, and up-regulat- ed expression of activation-induced cytidine deaminase and in- terferon-a in PBMCs from patients with SLE [J]. Mod Rheuma- tol, 2015,25(6) : 865-870.DOI: 10.3109/14397595.2015.1030102.
  • 7Mallone R, Mannering SI, Brooks-Worrell BM, et al. Isolation and preservation of peripheral blood mononuelear cells for anal- ysis of islet antigen-reactive T cell responses: position state- ment of the T-Cell Workshop Committee of the Immunology of Diabetes Society [J ]. Clin Exp Immunol, 2011,163 ( 1 ) : 33-49. DOI : 10.1111/j.1365-2249.2011.04272.x.
  • 8Lee CT, Harris SB, Retnakaran R, et al. White blood cell sub- types,insulin resistance and 13-cell dysfunction in high-risk indi- viduals-the PROMISE cohort [J].Clin Endocrinol (Oxf),2014, 81(4) :536-54l.DOI: 10.1111/cen.12390.
  • 9Zampetaki A, Kiechl S, Drozdov I, et ah Plasma microRNA pro- filing reveals loss of endothelial miR-126 and other microR- NAs in type 2 diabetes [J]. Circ Res,2010,107(6):810-817. DOI : 10.1161/CIRCRESAHA. 110.226357.
  • 10Bai Y,Bai X,Wang Z, et al. MicroRNA-126 inhibits ischemia- induced retinal ~ neovascularization via regulating angiogenic growth factors [J]. Exp Mol Pathol,2011,91(1):471-477.DOI: 10.1016/jyexmp.2011.04.016.

同被引文献36

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部